MB Growth Partners

MB Growth Partners is an investment firm based in Memphis, Tennessee, specializing in providing capital to early-stage medical device and biotechnology companies across the United States. Founded in 2001, the firm focuses on opportunities in New England and has successfully allocated over $140 million in private capital over the past decade. MB Growth Partners invests between $500,000 and $5 million, concentrating on innovative product solutions, particularly in the area of musculoskeletal diseases. The firm leverages its extensive industry experience and strategic relationships to support the growth and development of its portfolio companies.

Stephen Snowdy

Partner

James D. Witherington

Member of Financial Advisory Board

Past deals in Southeastern US

SweetBio

Seed Round in 2018
SweetBio, Inc. is a Memphis, Tennessee-based company that develops and manufactures innovative wound care solutions by bioengineering medical grade Manuka honey into advanced membranes. Founded in 2015, SweetBio aims to reduce complications and infections associated with various types of wounds, including pressure ulcers, diabetic ulcers, and surgical wounds. The company's flagship product, Apis, is a patented, FDA-cleared wound care patch that utilizes a unique combination of gelatin and nanoparticles to incorporate honey at a molecular level, resulting in a solid, durable patch that maintains a moist wound environment and manages exudate effectively. SweetBio has gained recognition through its participation in various accelerators and competitions, and has been featured in prominent media outlets.

Cast21

Seed Round in 2017
Cast21 has designed a light-weight, lattice-structure cast that is breathable and waterproof, eliminating many of the disadvantages of traditional casts. Its design also allows for the integration of electronic therapies to decrease healing time.

SweetBio

Pre Seed Round in 2015
SweetBio, Inc. is a Memphis, Tennessee-based company that develops and manufactures innovative wound care solutions by bioengineering medical grade Manuka honey into advanced membranes. Founded in 2015, SweetBio aims to reduce complications and infections associated with various types of wounds, including pressure ulcers, diabetic ulcers, and surgical wounds. The company's flagship product, Apis, is a patented, FDA-cleared wound care patch that utilizes a unique combination of gelatin and nanoparticles to incorporate honey at a molecular level, resulting in a solid, durable patch that maintains a moist wound environment and manages exudate effectively. SweetBio has gained recognition through its participation in various accelerators and competitions, and has been featured in prominent media outlets.

Restore Medical Solutions

Series A in 2015
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

EndoInSight

Seed Round in 2014
EndoInSight specializes in developing a disposable insufflation system aimed at alleviating the pain and discomfort associated with colonoscopy procedures used for colorectal cancer screening. The company utilizes carbon dioxide for colon inflation, a method that significantly reduces post-procedural discomfort compared to traditional air insufflation. Despite the known advantages of using CO2, its adoption in clinical settings has been limited due to low awareness and the high costs of existing insufflation systems. By offering a cost-effective solution, EndoInSight seeks to enhance patient comfort and improve overall outcomes in colorectal cancer treatment.

CrossRoads Extremity Systems

Venture Round in 2014
CrossRoads Extremity Systems, LLC is a medical device company based in Memphis, Tennessee, that specializes in the design, manufacture, and marketing of implant systems specifically for foot and ankle surgeries. Founded in 2014, the company offers a range of products, including the MotoBAND CP Plating System for midfoot and forefoot procedures, STRoPP implant kits, and the MotoCLIP, which aids in bone healing through innovative fixation techniques. Additionally, CrossRoads provides implants like the CrossTIE series for hammertoe correction and revision cases, as well as Allograft wedges and DBM putties. Their DynaFORCE hybrid fixation system enhances surgical flexibility and dynamic compression. The company also emphasizes sustainability through its EcoSMART instrument recovery service, which addresses waste in surgical environments. Products are distributed across the United States, aiming to improve surgical outcomes and operational efficiency in healthcare settings.

ECOSURG

Seed Round in 2014
EcoSurg™ (pronounced eek-oh-surj) is a developer of environmentally-friendly surgical supplies that is dedicated to reducing the carbon footprint of the surgical suite. Their flagship product is the EcoSurg™ line of Patient Positioners. Disposable patient positioners are used in over 20 Million surgical procedures per year in the United States alone. These foam shapes are used to properly position patients in a variety of positions, ensuring safety, comfort, and adequate access to the surgical site. When disposed of, however, these products are harmful to the environment as they are made from materials that consist largely of petroleum-based derivatives. These compounds and the other hazardous byproducts from their production are not only harmful to the environment, but also incur higher handling and disposal costs that are inevitably passed on to the Customer.

Innometrix

Seed Round in 2014
Innometrix, Inc. develops a technology that produces a biomechanical snapshot of the female pelvic floor that will give physicians better data prior to surgery. The company is based in Memphis, Tennessee.

Compression Kinetics

Seed Round in 2014
Compression Kinetics is developing the next generation of wearable technology, actively improving recovery time and athletic performance of its wearers. The pioneering dynamic compression technology fits into an $11b athletic compression apparel market. Compression Kinetics is transforming clinically proven compression therapy into a mobile, sleek and affordable wearable for the first time. With the active compression sleeve, any athlete can recover faster and improve their performance like the professionals.
Blood Monitoring Solutions, Inc. is a company based in Memphis, Tennessee, specializing in blood monitoring solutions aimed at preventing blood wastage. The company has developed a smart blood transport system that enables blood banks to continuously monitor the temperature and status of each blood unit. By employing a proactive, data-driven approach, Blood Monitoring Solutions enhances patient safety and helps reduce costs for hospitals globally.

CamPlex

Seed Round in 2014
CamPlex, founded in 2012 and headquartered in Germantown, Tennessee, operates in the healthcare sector as a manufacturer of high-quality fiber optic solutions. The company specializes in fiber optic-based camera adapter systems and broadcast-grade interface gear. These products are designed to enhance performance and extend signal transmission capabilities, thereby facilitating easier and more efficient signal delivery for broadcast professionals. By providing these innovative solutions, CamPlex helps reduce operating costs by minimizing the need for additional components and expensive replacements.

Tidal Wave Technology

Seed Round in 2014
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Hubble Telemedical

Series A in 2014
Hubble Telemedical is dedicated to enabling earlier detection of systemic and debilitating diseases that manifest in the retina - the light-sensitive membrane at the back of the eye that transmits visual information to the brain - for more effective treatment and patient care. In addition to eye diseases such as retinopathy, macular degeneration and glaucoma, a range of systemic diseases such cardiovascular and immune diseases can be detected in the retina. Early diagnosis is essential for effective treatment of these diseases. Unfortunately, many at-risk individuals do not receive annual retinal exams due to inconvenience or unavailability. The result is that many individuals go undiagnosed until severe damage has occurred, causing medical complications and increased healthcare costs. They are changing that paradigm. Thanks to their proprietary, award-winning Telemedical Retinal Image Analysis and Diagnosis (TRIAD™) technology, Hubble Telemedical enables screening and diagnosis where and when it is most convenient for the healthcare consumer. They partner with healthcare providers, insurance companies, and employers to bring the power of retinal screening to the consumer. Their services are fully HIPAA-compliant, secure, and easy to use –- and multi-site, peer-reviewed and published clinical studies have demonstrated their ability to dramatically increase annual screening compliance, thereby decreasing overall healthcare costs and, most importantly, improving patients' health. They invite you to contact us to learn more about their services and technology— and how they can work with you to bring the power of retinal image analysis to your organization.

Restore Medical Solutions

Series A in 2014
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

Mobilizer

Seed Round in 2014
Mobilizer Inc., a graduate of the ZeroTo510 medical device startup accelerator, has created a six-wheeled holster for medical equipment in order to make medical ambulation easier and faster.

Hapten Sciences

Venture Round in 2014
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. develops a screening equipment using a technology known as photoscreening to screen children’s vision for vision problems. The Company provides a fast, easy, and portable pediatric vision screening solution for infants and pre-school and school-age children. The company was formerly known as iScreen, LLC and changed its name in April 2009. iScreen Vision, Inc. was incorporated in 2009 and is based in Cordova, Tennessee.

View Medical

Seed Round in 2013
View Medical, Inc., founded in 2013 and based in Memphis, Tennessee, specializes in surgical lighting systems designed to enhance visibility during deep cavity surgeries. The company's flagship product, the SurgiLight, features a high-quality LED light source that connects seamlessly to existing overhead surgical lights. With a flexible cable that extends down from the overhead fixture, SurgiLight allows surgeons to direct bright, localized illumination onto the surgical site from any angle, addressing a critical need for improved lighting in operating rooms. This innovative solution aims to mitigate the risk of surgical errors, which impose a significant financial burden on the U.S. healthcare system. By providing a practical and effective lighting alternative to cumbersome surgical headlights, View Medical enhances operating conditions and ultimately contributes to better patient outcomes.

Mobilizer

Seed Round in 2013
Mobilizer Inc., a graduate of the ZeroTo510 medical device startup accelerator, has created a six-wheeled holster for medical equipment in order to make medical ambulation easier and faster.

BioNanovations

Seed Round in 2013
Bell BioNanonostics Corp. focuses on monitoring of bacterial infection. Bell BioNanonostics Corp. is based in the United States.

Focal Point Pharmaceuticals

Seed Round in 2013
Focal Point Pharmaceuticals is a healthcare company focused on pharmaceutical businesses. It was incorporated in 2013 and is based in Memphis, Tennessee, United States.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. develops a screening equipment using a technology known as photoscreening to screen children’s vision for vision problems. The Company provides a fast, easy, and portable pediatric vision screening solution for infants and pre-school and school-age children. The company was formerly known as iScreen, LLC and changed its name in April 2009. iScreen Vision, Inc. was incorporated in 2009 and is based in Cordova, Tennessee.

ECOSURG

Seed Round in 2013
EcoSurg™ (pronounced eek-oh-surj) is a developer of environmentally-friendly surgical supplies that is dedicated to reducing the carbon footprint of the surgical suite. Their flagship product is the EcoSurg™ line of Patient Positioners. Disposable patient positioners are used in over 20 Million surgical procedures per year in the United States alone. These foam shapes are used to properly position patients in a variety of positions, ensuring safety, comfort, and adequate access to the surgical site. When disposed of, however, these products are harmful to the environment as they are made from materials that consist largely of petroleum-based derivatives. These compounds and the other hazardous byproducts from their production are not only harmful to the environment, but also incur higher handling and disposal costs that are inevitably passed on to the Customer.

Cuff-Protect

Seed Round in 2013
Cuff-Mate skin barriers offer healthcare professionals a cost-effective way to protect their patients, themselves and equipment when taking vital signs.

Hapten Sciences

Seed Round in 2013
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

Hubble Telemedical

Seed Round in 2013
Hubble Telemedical is dedicated to enabling earlier detection of systemic and debilitating diseases that manifest in the retina - the light-sensitive membrane at the back of the eye that transmits visual information to the brain - for more effective treatment and patient care. In addition to eye diseases such as retinopathy, macular degeneration and glaucoma, a range of systemic diseases such cardiovascular and immune diseases can be detected in the retina. Early diagnosis is essential for effective treatment of these diseases. Unfortunately, many at-risk individuals do not receive annual retinal exams due to inconvenience or unavailability. The result is that many individuals go undiagnosed until severe damage has occurred, causing medical complications and increased healthcare costs. They are changing that paradigm. Thanks to their proprietary, award-winning Telemedical Retinal Image Analysis and Diagnosis (TRIAD™) technology, Hubble Telemedical enables screening and diagnosis where and when it is most convenient for the healthcare consumer. They partner with healthcare providers, insurance companies, and employers to bring the power of retinal screening to the consumer. Their services are fully HIPAA-compliant, secure, and easy to use –- and multi-site, peer-reviewed and published clinical studies have demonstrated their ability to dramatically increase annual screening compliance, thereby decreasing overall healthcare costs and, most importantly, improving patients' health. They invite you to contact us to learn more about their services and technology— and how they can work with you to bring the power of retinal image analysis to your organization.

AIS

Seed Round in 2013
Although it is still relatively new, AIS, having a relationship with other biology-inspired computing models, and computational biology.

Mobilizer

Seed Round in 2013
Mobilizer Inc., a graduate of the ZeroTo510 medical device startup accelerator, has created a six-wheeled holster for medical equipment in order to make medical ambulation easier and faster.

Health & Bliss

Seed Round in 2013
Health & Bliss Inc. is a medical device company based in Memphis, Tennessee, specializing in the design, patenting, and sale of medical products and diagnostic tests. The company has developed Strep Test Anywhere, an innovative point-of-care device that enables testing for multiple infections, including strep throat, influenza A/B, chlamydia, gonorrhea, hepatitis B/C, and several other illnesses. By providing a means to obtain accurate test results without the need for a doctor visit, Health & Bliss aims to address significant barriers to effective healthcare, specifically time and cost. Their technology is designed to improve patient access to diagnostic services while benefiting healthcare providers and payers alike.

SurgiLight

Seed Round in 2013
SurgiLight offers a surgical lighting system that provides surgeons with a practical illumination device, enabling them to focus on target areas.

Tidal Wave Technology

Seed Round in 2013
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Hubble Telemedical

Seed Round in 2012
Hubble Telemedical is dedicated to enabling earlier detection of systemic and debilitating diseases that manifest in the retina - the light-sensitive membrane at the back of the eye that transmits visual information to the brain - for more effective treatment and patient care. In addition to eye diseases such as retinopathy, macular degeneration and glaucoma, a range of systemic diseases such cardiovascular and immune diseases can be detected in the retina. Early diagnosis is essential for effective treatment of these diseases. Unfortunately, many at-risk individuals do not receive annual retinal exams due to inconvenience or unavailability. The result is that many individuals go undiagnosed until severe damage has occurred, causing medical complications and increased healthcare costs. They are changing that paradigm. Thanks to their proprietary, award-winning Telemedical Retinal Image Analysis and Diagnosis (TRIAD™) technology, Hubble Telemedical enables screening and diagnosis where and when it is most convenient for the healthcare consumer. They partner with healthcare providers, insurance companies, and employers to bring the power of retinal screening to the consumer. Their services are fully HIPAA-compliant, secure, and easy to use –- and multi-site, peer-reviewed and published clinical studies have demonstrated their ability to dramatically increase annual screening compliance, thereby decreasing overall healthcare costs and, most importantly, improving patients' health. They invite you to contact us to learn more about their services and technology— and how they can work with you to bring the power of retinal image analysis to your organization.

ECOSURG

Seed Round in 2012
EcoSurg™ (pronounced eek-oh-surj) is a developer of environmentally-friendly surgical supplies that is dedicated to reducing the carbon footprint of the surgical suite. Their flagship product is the EcoSurg™ line of Patient Positioners. Disposable patient positioners are used in over 20 Million surgical procedures per year in the United States alone. These foam shapes are used to properly position patients in a variety of positions, ensuring safety, comfort, and adequate access to the surgical site. When disposed of, however, these products are harmful to the environment as they are made from materials that consist largely of petroleum-based derivatives. These compounds and the other hazardous byproducts from their production are not only harmful to the environment, but also incur higher handling and disposal costs that are inevitably passed on to the Customer.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Nanophthalmics

Seed Round in 2012
Nanophthalmics has developed and is licensing a patent-pending platform technology for microfabricated instruments that engage tissue in entirely new ways. Their focus is on employing novel surgical devices, techniques, and materials to improve current treatment outcomes for ophthalmic and other microsurgical diseases. Their first commercial device is a disposable, 510(k) exempt, corneal micro-punch that enhances healing of abrasions, recurrent erosions, and other corneal diseases by modifying tissue attachments at a cellular level.

Urova Medical

Seed Round in 2012
Urova Medical was founded in Memphis, TN with the goal of providing a novel solution to cure stress urinary incontinence safely, effectively, and conveniently. Urova Medical’s technology was developed by an undergraduate team of talented biomedical engineers at Johns Hopkins University. The implant was designed extensively under the mentorship of physicians from the Johns Hopkins Hospital, the number one urological center in the US. Urova Medical has been part of the Zeroto510 Accelerator program sponsored by Innova Fund and MB Ventures, both venture capital firms based in Memphis

BioNanovations

Seed Round in 2012
Bell BioNanonostics Corp. focuses on monitoring of bacterial infection. Bell BioNanonostics Corp. is based in the United States.

S2 Interactive

Seed Round in 2012
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.

Hubble Telemedical

Seed Round in 2012
Hubble Telemedical is dedicated to enabling earlier detection of systemic and debilitating diseases that manifest in the retina - the light-sensitive membrane at the back of the eye that transmits visual information to the brain - for more effective treatment and patient care. In addition to eye diseases such as retinopathy, macular degeneration and glaucoma, a range of systemic diseases such cardiovascular and immune diseases can be detected in the retina. Early diagnosis is essential for effective treatment of these diseases. Unfortunately, many at-risk individuals do not receive annual retinal exams due to inconvenience or unavailability. The result is that many individuals go undiagnosed until severe damage has occurred, causing medical complications and increased healthcare costs. They are changing that paradigm. Thanks to their proprietary, award-winning Telemedical Retinal Image Analysis and Diagnosis (TRIAD™) technology, Hubble Telemedical enables screening and diagnosis where and when it is most convenient for the healthcare consumer. They partner with healthcare providers, insurance companies, and employers to bring the power of retinal screening to the consumer. Their services are fully HIPAA-compliant, secure, and easy to use –- and multi-site, peer-reviewed and published clinical studies have demonstrated their ability to dramatically increase annual screening compliance, thereby decreasing overall healthcare costs and, most importantly, improving patients' health. They invite you to contact us to learn more about their services and technology— and how they can work with you to bring the power of retinal image analysis to your organization.

Urova Medical

Seed Round in 2012
Urova Medical was founded in Memphis, TN with the goal of providing a novel solution to cure stress urinary incontinence safely, effectively, and conveniently. Urova Medical’s technology was developed by an undergraduate team of talented biomedical engineers at Johns Hopkins University. The implant was designed extensively under the mentorship of physicians from the Johns Hopkins Hospital, the number one urological center in the US. Urova Medical has been part of the Zeroto510 Accelerator program sponsored by Innova Fund and MB Ventures, both venture capital firms based in Memphis

HandMinder

Seed Round in 2012
Currently, there are 7M stroke survivors in the US. Additionally, there are more than 795K new or recurrent stroke survivors every year. Americans pay $73.7B annually for stroke-related medical costs and disability. Approximately 60% of them suffer from hand dysfunction. Current treatments and devices for hand dysfunction focus primarily on muscle rehabilitation, with the patient taking a passive role. Further, these interventions are expensive and inconvenient. Current treatments are inadequate, as recent studies show that active engagement of the brain during hand rehabilitation improves the amount of hand movement by 2x over traditional treatments and further improves the quality of hand movement by 2.5x over these traditional methods. Based on this research, we created the HandMinder portable hand rehabilitation device which employs patent-pending vibration-guided brain engagement technology that strengthens the neural connections between the hand and brain, producing marked improvement in patients’ hand function. Further, HandMinder is affordable, convenient, and used in clinical settings and at home.

Hapten Sciences

Seed Round in 2012
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

Restore Medical Solutions

Seed Round in 2012
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

ECOSURG

Seed Round in 2012
EcoSurg™ (pronounced eek-oh-surj) is a developer of environmentally-friendly surgical supplies that is dedicated to reducing the carbon footprint of the surgical suite. Their flagship product is the EcoSurg™ line of Patient Positioners. Disposable patient positioners are used in over 20 Million surgical procedures per year in the United States alone. These foam shapes are used to properly position patients in a variety of positions, ensuring safety, comfort, and adequate access to the surgical site. When disposed of, however, these products are harmful to the environment as they are made from materials that consist largely of petroleum-based derivatives. These compounds and the other hazardous byproducts from their production are not only harmful to the environment, but also incur higher handling and disposal costs that are inevitably passed on to the Customer.

Veracity Medical Solutions

Seed Round in 2012
Veracity Medical Solutions, Inc., established in 2007 and located in Collierville, Tennessee, focuses on contract manufacturing within the medical device industry. The company offers a comprehensive range of services, from sourcing raw materials to producing finished products that are laser marked and packaged. It also provides design and development services, prototyping, and customization to meet specific client needs. As of January 2018, Veracity Medical Solutions operates as a subsidiary of Arcamed, LLC.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Calosyn Pharma

Seed Round in 2009
CaloSyn Pharma, Inc. is a biopharmaceutical company focused on developing intra-articular therapeutics specifically for osteoarthritis (OA), a condition affecting over 27 million people in the United States and more than 100 million globally. Founded in 2007 and headquartered in Boston, Massachusetts, with additional offices in Shreveport, Louisiana, and Atlanta, Georgia, the company is advancing a novel approach to OA treatment through the use of calcium channel blockers, drugs traditionally employed in heart and vascular disease management. By leveraging new insights into the mechanisms of these drugs and the processes underlying joint damage and pain in osteoarthritis, CaloSyn Pharma aims to reformulate and repurpose these medications for direct injection into affected joints. The company is currently conducting a Phase II clinical trial in the United States to evaluate the efficacy of its therapeutic approach.

Protein Discovery

Series C in 2008
Protein Discovery, Inc., a life sciences company, develops and commercializes sample preparation technologies that enable protein and peptide analysis using mass spectrometry. It provides Gelfree 8100, a fractionation system that partitions complex protein mixtures into liquid-phase molecular weight fractions; Passport 1200, a sample preparation system that enriches low molecular weight proteins and peptides, and removes matrix interferences for high-throughput quantification applications; and PPS Silent Surfactant, a protein preparation reagent that solubilizes membrane proteins and cleaves to eliminate detergent interference. The company also provides UPX universal protein extraction kit for detergent extraction of proteins from cells and tissues. It serves life science researchers and drug development scientists. The company markets its products through Agilent Technologies, as well as online in the United States and internationally. Protein Discovery, Inc. was founded as Qgenics Biosciences, Inc. in 2001 and changed its name to Protein Discovery, Inc. in April 2004. The company is based in Knoxville, Tennessee.

BioMimetic Therapeutics

Series C in 2005
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.

BioMimetic Therapeutics

Series C in 2004
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.

Alveolus

Series B in 2004
Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.

GTx

Series E in 2003
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.

BioMimetic Therapeutics

Series B in 2003
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.